Results 181 to 190 of about 62,912 (312)

Janus Kinase Inhibitors for the Treatment of Pediatric Morphea: A Systematic Review

Pediatric Dermatology, EarlyView.
ABSTRACT Morphea, also known as localized scleroderma (LoS), is an inflammatory, fibrosing dermatologic disorder of the skin and underlying tissues with associated comorbidities including joint contractures, limb‐length discrepancies, and inflammatory arthropathy occurring more commonly in children.
Alexa Moschella, Celina DeBiasio, Carmen Liy‐Wong   +2 more
wiley   +1 more source

Research progress on tofacitinib in the treatment of chronic actinic dermatitis

Pifu-xingbing zhenliaoxue zazhi
Chronic actinic dermatitis (CAD) is a group of immune-mediated diseases characterized by photosensitivity. Tofacitinib, a Janus kinase (JAK) 1/3 inhibitor, is currently the most extensively reported and widely used JAK inhibitor for the treatment of CAD.
WU Hui, SHEN Haojia, HE Zezhi, CHEN Jiaoquan, LI Runxiang, ZHU Huilan   +5 more
doaj   +1 more source

Improvements in PET/CT results and serum cytokine profile of HLA-B52-positive patients with Takayasu's arteritis and ulcerative colitis post-tofacitinib

, 2021
Kazuma Ino, Nana Kinoshita, Yoshiyuki Arinuma, Yu Matsueda, Kunihiro Yamaoka   +4 more
openalex   +2 more sources

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

P452 Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis [PDF]

, 2022
Meredith McNally, Eoin Keating, Emma L. Gray, Emma McCormick, A Carroll, Christina G.S. Palmer, Úna Kennedy, Susan McKiernan, F MacCarthy, Cara Dunne, Karen Hartery, Laurence J. Egan, Eoin Slattery, Barbara M. Ryan, Deirdre McNamara, Anthony O’Connor, Niall Breslin, Sarah O’Donnell, G Cullen, Hugh Mulcahy, Juliette Sheridan, Glen Doherty, David Kevans   +22 more
openalex   +1 more source

Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis

ACR Open Rheumatology, Volume 8, Issue 2, February 2026.
Objective Interstitial lung disease (ILD) is common in idiopathic inflammatory myositis (IIM), particularly in antisynthetase syndrome (ASyS), antimelanoma differentiation‐associated protein 5 (anti‐MDA5) syndrome, and scleromyositis. ILD can progress despite resolution of extrapulmonary symptoms, termed postmyopathic progressive pulmonary fibrosis ...
Julia Clark, Dora Chan, Damon Dhillon, Jan Dutz, Gillian Goobie, Kun Huang   +5 more
wiley   +1 more source

AB0403 Adherence and access to biological therapy and tofacitinib in a cohort of colombian patients with rheumatological diseases [PDF]

, 2017
J Machado-Alba, ME Machado-Duque, S Granada, on behalf of Grupo de Investigaciόn en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnolόgica de Pereira-Audifarma S.A, Pereira, Colombia   +3 more
openalex   +1 more source

P583 Tofacitinib for acute severe ulcerative colitis: a systematic review [PDF]

, 2023
Pernille Dige Ovesen, J. Brynskov, Jakob Benedict Seidelin, Carina Bjørnskov Steenholt   +3 more
openalex   +1 more source

No Increased Risk of Thromboembolic Events During 6‐Month Treatment With Baricitinib in Patients With Alopecia Areata

International Journal of Dermatology, EarlyView.
Giacomo Caldarola, Antonietta Ferretti, Lorenzo Maria Pinto, Leonardo Di Gennaro, Eleonora De Luca, Gennaro Marco Falco, Clara De Simone, Raimondo De Cristofaro, Ketty Peris   +8 more
wiley   +1 more source

Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort

International Journal of Dermatology, EarlyView.
Alonso García‐Núñez, Antonio Alcalá Ramírez Del Puerto, Roberto Daza‐García, María Teresa Monserrat‐García, Mercedes Morillo‐Andújar, Javier Jesús Domínguez‐Cruz, Román Barabash‐Neila   +6 more
wiley   +1 more source